Advancements in theoretical and experimental investigations on diamane materials
Nanoscale · 2023
DOI: 10.1039/d3nr01400b ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanoscale, 2023. Verfasst von Bowen Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Nanosystem and Hierarchical Fabrication, National Center for Nanoscience and Technology (NCNST), Beijing 100190, China. wangb@n…. Hauptthemen laut MEDLINE: Graphite. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Chinese Academy of Sciences.
Abstract (Originalsprache)
We summarize the recent theoretical and experimental studies on diamane in its pristine form and functionalized with substituents in terms of atomic structure, synthesis strategies, physical properties, and potential technological applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory of Nanosystem and Hierarchical Fabrication, National Center for Nanoscience and Technology (NCNST), Beijing 100190, China. wangb@nanoctr.cn.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China. liangtao@ucas.ac.cn.
Förderung
- National Key Research and Development Program of China
- Chinese Academy of Sciences
Zitieren
APA
Liu, B., Emmanuel, E., Liang, T., & Wang, B. (2023). Advancements in theoretical and experimental investigations on diamane materials. Nanoscale. https://doi.org/10.1039/d3nr01400b
Vancouver
Liu B, Emmanuel E, Liang T, Wang B. Advancements in theoretical and experimental investigations on diamane materials. Nanoscale. 2023. doi:10.1039/d3nr01400b
BibTeX
@article{Liu2023,
author = {Liu, Bowen and Emmanuel, Emilia and Liang, Tao and Wang, Bin},
title = {Advancements in theoretical and experimental investigations on diamane materials},
journal = {Nanoscale},
year = {2023},
doi = {10.1039/d3nr01400b}
}
EUVIMED